Overview

Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients

Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to investigate the effects of dexmedetomidine infusion on the stress response to intubation, postoperative analgesia, and renal functions (urinary output [UOP], creatinine and glomerular filtration rate [GFR]) in preeclamptic patient.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Assiut University
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- pregnant women

- have mild preeclampsia ( Pre-eclamptic patients will be defined as having hypertension
[systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP)≥90
mmHg] accompanied by proteinuria first detected after 20 weeks of gestation).

- Proteinuria is defined as at least 300 mg protein in 24 h urine collection [or ≥1+
dipstick (30 mg/dl) in a single urine sample] ).

- American Society of Anesthesiologists (ASA) physical status of II or III.

- age between 19 and 40 years

Exclusion Criteria:

- patient refusal to consent (obsolete).

- pre-existing neurological disease or psychic patients.

- history of cardiac and respiratory system failure.

- co-existing significant renal or liver disease.